4th Quarter - Termination
MARTIN GREEN for FABIANI & COMPANY ON BEHALF OF ALNYLAM PHARMACEUTICALS
Firm
Income
—
Expenses
—
Terminated
Dec 23, 2010
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Patenting of genetic sequences
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTIN GREEN | Deputy Chief of Staff, Rep. Mark Souder |
Copyright/Patent/Trademark CPT
Patent reform legislation, including S. 510
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTIN GREEN | Deputy Chief of Staff, Rep. Mark Souder |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.